Correlations of Vascular Architecture and Angiogenesis with Pituitary Adenoma Histotype

Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions

(2014) Naveen S. Vasudev et al.   ANGIOGENESIS

Endocan, a new invasion and angiogenesis marker of pituitary adenomas

(2014) Fumihiro Matano et al.   JOURNAL OF NEURO-ONCOLOGY

Antiangiogenic Therapy Inhibits the Recruitment of Vascular Accessory Cells to the Perivascular Niche in Glioma Angiogenesis

(2014) G. Parmaksız et al.   JOURNAL OF VASCULAR RESEARCH

Hypercortisolism Is Associated With Increased Coronary Arterial Atherosclerosis: Analysis of Noninvasive Coronary Angiography Using Multidetector Computerized Tomography

(2013) Nicola M. Neary et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Microvascular morphometrics of the hypophysis and pituitary tumors: From bench to operating theatre

(2013) Antonio Di Ieva et al.   MICROVASCULAR RESEARCH

Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization

(2012) Sheng-Fu Cheng et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Reprint of “Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells”

(2012) Napoleone Ferrara   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prolactin and blood vessels: A comparative endocrinology perspective

(2012) Carmen Clapp et al.   GENERAL AND COMPARATIVE ENDOCRINOLOGY

Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors

(2012) Shingo Takano et al.   JOURNAL OF NEURO-ONCOLOGY

Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence

(2012) Ruth Sánchez-Ortiga et al.   Pituitary

Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?

(2011) Anne Q. Reuwer et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

La prolactine et son fragment 16 kDa dans les tissus de mammifères

(2011) Mustapha Lkhider et al.   M S-MEDECINE SCIENCES

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

(2011) J. F. de Groot et al.   NEURO-ONCOLOGY

Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration

(2011) James J. Logie et al.   PLoS One

The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation

(2011) Ngoc-Quynh-Nhu Nguyen et al.   PLoS One

High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins

(2010) E. Arnold et al.   DIABETES

VEGF and CD31 Association in Pituitary Adenomas

(2010) Carolina Cristina et al.   ENDOCRINE PATHOLOGY

Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes

(2010) F. ROTONDO et al.   NEOPLASMA

Microvessel Density and Area in Pituitary Microadenomas

(2009) Ewa Jasek et al.   ENDOCRINE PATHOLOGY

Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia

(2009) Ryutaro Nomura et al.   JOURNAL OF NEURO-ONCOLOGY

Peptide Hormone Regulation of Angiogenesis

(2009) Carmen Clapp et al.   PHYSIOLOGICAL REVIEWS

Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin

(2008) Tomoya Kitamura et al.   NATURE CELL BIOLOGY

High-grade glioma before and after treatment with radiation and Avastin: Initial observations

(2008) Ingeborg Fischer et al.   NEURO-ONCOLOGY

Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker

(2008) Cristina B. Pizarro et al.   NEUROPATHOLOGY